618 related articles for article (PubMed ID: 24333902)
1. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
Ferrero C; Jiménez-Castellanos MR
Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
[TBL] [Abstract][Full Text] [Related]
2. Invivo absorption behaviour of theophylline from starch-methyl methacrylate matrix tablets in beagle dogs.
Fernández-Campos F; Ferrero C; Colom H; Jiménez-Castellanos MR
Int J Pharm; 2015 Jan; 478(2):684-92. PubMed ID: 25476254
[TBL] [Abstract][Full Text] [Related]
3. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
Marinich JA; Ferrero C; Jiménez-Castellanos MR
Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
[TBL] [Abstract][Full Text] [Related]
4. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
[TBL] [Abstract][Full Text] [Related]
5. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers. II. Effect of HPMC with different degrees of methoxy/hydroxypropyl substitution.
Escudero JJ; Ferrero C; Jiménez-Castellanos MR
Int J Pharm; 2010 Mar; 387(1-2):56-64. PubMed ID: 19969052
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
7. Formulation development and in vitro evaluation of theophylline microcapsules.
Ahmad M; Akhtar N; Murtaza G; Hussain SW
Pak J Pharm Sci; 2012 Jan; 25(1):15-9. PubMed ID: 22186304
[TBL] [Abstract][Full Text] [Related]
8. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers: effect of HPMC of different viscosity grades.
Escudero JJ; Ferrero C; Jiménez-Castellanos MR
Int J Pharm; 2008 Mar; 351(1-2):61-73. PubMed ID: 17996408
[TBL] [Abstract][Full Text] [Related]
9. Drug release kinetics and fronts movement studies from methyl methacrylate (MMA) copolymer matrix tablets: effect of copolymer type and matrix porosity.
Ferrero C; Bravo I; Jiménez-Castellanos MR
J Control Release; 2003 Sep; 92(1-2):69-82. PubMed ID: 14499186
[TBL] [Abstract][Full Text] [Related]
10. Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release.
Li L; Wang L; Li J; Jiang S; Wang Y; Zhang X; Ding J; Yu T; Mao S
Int J Pharm; 2014 Dec; 476(1-2):253-65. PubMed ID: 25290814
[TBL] [Abstract][Full Text] [Related]
11. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
12. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of the USP III apparatus.
Asare-Addo K; Kaialy W; Levina M; Rajabi-Siahboomi A; Ghori MU; Supuk E; Laity PR; Conway BR; Nokhodchi A
Colloids Surf B Biointerfaces; 2013 Apr; 104():54-60. PubMed ID: 23298588
[TBL] [Abstract][Full Text] [Related]
13. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
[TBL] [Abstract][Full Text] [Related]
14. Effect of the molecular size of carboxymethylcellulose and some polymers on the sustained release of theophylline from a hydrophilic matrix.
Emeje MO; Kunle OO; Ofoefule SI
Acta Pharm; 2006 Sep; 56(3):325-35. PubMed ID: 19831281
[TBL] [Abstract][Full Text] [Related]
15. Compaction properties, drug release kinetics and fronts movement studies of matrices combining mixtures of swellable and inert polymers. III: effect of polymer substitution type.
Escudero JJ; Ferrero C; Casas M; Jiménez-Castellanos MR
Int J Pharm; 2012 Sep; 434(1-2):215-23. PubMed ID: 22633903
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of ethylcellulose as matrices for controlled release drug delivery.
Quadir MA; Chanda E; Haider SS; Reza MD; Datta BK
Pak J Pharm Sci; 2005 Apr; 18(2):29-34. PubMed ID: 16431395
[TBL] [Abstract][Full Text] [Related]
17. Study of dissolution hydrodynamic conditions versus drug release from hypromellose matrices: the influence of agitation sequence.
Asare-Addo K; Levina M; Rajabi-Siahboomi AR; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):452-60. PubMed ID: 20729043
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
Uhumwangho MU; Okor RS
Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
[TBL] [Abstract][Full Text] [Related]
19. Interpolymer complexation between copovidone and carbopol and its effect on drug release from matrix tablets.
Zhang F; Meng F; Wang ZY; Na W
Drug Dev Ind Pharm; 2017 Feb; 43(2):190-203. PubMed ID: 27599027
[TBL] [Abstract][Full Text] [Related]
20. [Comparative evaluation using in vitro dissolution tests of various sustained release theophylline preparations].
Kissné CE
Acta Pharm Hung; 1990 Nov; 60(5-6):191-6. PubMed ID: 2087990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
